Stock Price
368.25
Daily Change
0.19%
Yearly
20.94%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 121.51 0.16 0.13% 12.83%
Alcon AG 76.52 1.94 2.60% 34.72%
Almirall SA 10.67 0.11 1.04% -0.56%
Amgen 211.32 2.53 1.21% -7.70%
Artemis Alpha 400.00 5.00 1.27% 4.17%
AstraZeneca 8,223.00 -140.00 -1.67% 1.09%
Bayer 45.71 1.13 2.52% -3.14%
Biogen 226.83 2.72 1.21% -7.95%
Bristol-Myers Squibb 57.13 0.30 0.53% -6.53%
Fresenius Medical Care 56.04 0.28 0.50% -17.97%
Fresenius 34.90 0.42 1.20% -7.05%
Genmab 2,486.00 60.00 2.47% 3.80%
Gilead Sciences 69.65 0.15 0.22% 13.86%
Galapagos 45.90 2.59 5.98% -53.12%
GRIFOLS 15.30 0 0% -34.02%
GlaxoSmithKline 1,575.80 21.00 1.35% 12.16%
Hikma Pharmaceutical 2,266.00 -13.00 -0.57% -10.26%
Eli Lilly 245.11 -1.22 -0.50% 64.17%
Lonza Group 730.60 24.40 3.46% 32.55%
H Lundbeck A/S 164.90 4.10 2.55% -13.89%
Merck 221.00 4.70 2.17% 61.73%
Merck & Co 72.28 -1.14 -1.55% -13.10%
Novartis 74.85 0.22 0.29% -7.82%
Orion 34.69 -0.28 -0.80% -11.60%
Pfizer 51.72 0.24 0.47% 21.52%
Philips 31.05 0.25 0.80% -26.98%
Recordati 55.26 1.44 2.68% 26.57%
Regeneron Pharmaceuticals 635.09 10.09 1.61% 27.75%
Roche Holding 368.25 0.70 0.19% 20.94%
Sanofi 85.36 1.01 1.20% 3.62%
UCB 98.72 1.42 1.46% 11.32%

Indexes Price Day Year
CH20 12514 138.27 1.12% 20.39%

Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.